metabolic engineering – Page 2

Genetic regulation of l-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis

mycolabadmin

Researchers studied how magic mushrooms (Psilocybe mexicana) regulate their chemistry to produce psilocybin, the psychoactive compound. They found that when mushrooms start fruiting, they turn on genes that make tryptophan (an amino acid building block) and turn off genes that break it down, directing all the tryptophan toward psilocybin production. This coordinated genetic control ensures the mushroom has enough of this key ingredient. This knowledge could help grow these mushrooms in labs for legitimate medical research into treating depression.

Comparative proteomics reveals the mechanism of cyclosporine production and mycelial growth in Tolypocladium inflatum affected by different carbon sources

mycolabadmin

Scientists studied how different sugar sources (fructose versus sucrose) affect the production of cyclosporine A, an important drug used to prevent organ rejection after transplants. Using advanced protein analysis techniques, they identified which proteins were more active in each sugar environment and discovered that fructose promotes drug production while sucrose promotes fungal growth. This research could help pharmaceutical companies produce cyclosporine more efficiently by identifying key proteins to enhance.

Improving the production of micafungin precursor FR901379 in Coleophoma empetri using heavy-ion irradiation and its mechanism analysis

mycolabadmin

Researchers used heavy-ion radiation to create improved strains of a fungus that produces a precursor to micafungin, an important antifungal drug. The improved strains produced over 3.5 times more of the desired compound than the original strain. By analyzing the genetic changes in these improved strains, the scientists identified which genes were most important for boosting production, helping guide future improvements in manufacturing this life-saving medicine.

Towards engineering agaricomycete fungi for terpenoid production

mycolabadmin

Mushroom-forming fungi, particularly species like shiitake and oyster mushrooms, naturally produce valuable compounds called terpenoids used in medicines, food, and cosmetics. Scientists are learning to genetically engineer these fungi to produce even larger amounts of these beneficial compounds, potentially making them as important to biotechnology as baker’s yeast and mold have been historically. This could create new sustainable sources for medicinal compounds and industrial chemicals.

Morphological Engineering of Filamentous Fungi: Research Progress and Perspectives

mycolabadmin

Filamentous fungi are microscopic organisms used to produce important enzymes and chemicals in industries. However, their growth forms during fermentation vary significantly and affect product quality. Scientists are developing methods to control how these fungi grow, both by adjusting fermentation conditions like temperature and oxygen levels, and by using genetic engineering to modify their growth patterns. These approaches help improve industrial production of medicines, enzymes, and other useful compounds.

Biosynthesis of mushroom-derived type II ganoderic acids by engineered yeast

mycolabadmin

Scientists successfully engineered baker’s yeast to produce ganoderic acids, potent anti-cancer compounds from medicinal mushrooms, at much higher levels than found in farmed mushrooms. By identifying key enzymes responsible for converting simpler compounds into active ganoderic acids, researchers created yeast strains that produce these valuable compounds 100-10,000 times more efficiently than traditional mushroom farming. This breakthrough could make these expensive medicinal compounds more accessible and affordable for medical research and potential drug development.

Improving the production of micafungin precursor FR901379 in Coleophoma empetri using heavy-ion irradiation and its mechanism analysis

mycolabadmin

Scientists successfully improved the production of a key ingredient for the antifungal drug micafungin by using heavy-ion radiation to create improved strains of a fungus called Coleophoma empetri. The best mutant strain produced over 250% more of the desired compound than the original strain. By analyzing the genetic changes in these improved strains, researchers identified specific genes related to fungal structure and metabolism that contribute to higher production, providing insights for future improvements to the manufacturing process.

Genetic Ablation of the Conidiogenesis Regulator Enhances Mycoprotein Production

mycolabadmin

Researchers created genetically modified versions of a fungus (Fusarium venenatum) used to make mycoprotein, a meat alternative. By removing a gene controlling spore formation, they increased fungal growth by 22%, which could significantly reduce production costs. The modified fungus also contained more amino acids and showed no safety concerns in lab tests, making it a promising advancement for sustainable food production.

Engineered biosynthesis and characterization of disaccharide-pimaricin

mycolabadmin

Scientists engineered a bacterium to produce a modified antibiotic called disaccharide-pimaricin that fights fungal infections with much better safety. This new compound dissolves better in water (107 times more soluble) and is much less toxic to human blood cells (12.6 times safer) compared to regular pimaricin, while still maintaining antifungal effectiveness. Through optimized fermentation processes, they achieved high production yields of 138 mg/L, making this a promising candidate for safer antifungal treatments.

Relative contribution of three transporters to D-xylose uptake in Aspergillus niger

mycolabadmin

Researchers studied how three different protein transporters help the fungus Aspergillus niger absorb xylose, a type of sugar found in plant waste. They found that two of these transporters (XltA and XltD) were equally important, while the third (XltB) played a minor role. Interestingly, the fungus could still absorb xylose even without these three transporters, suggesting other backup transporters exist. This finding shows that predicting which transporters are important based on laboratory tests in yeast may not accurately reflect how they work in the original fungus.

Research Topic: metabolic engineering